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Abstract
Background: Endoplasmic reticulum (ER) stress has been suggested to play a role in inflammatory bowel disease (IBD). The
three branches (ATF6, IRE1 and PERK) of the unfolded protein response (UPR) have different roles and are not necessarily
activated simultaneously.
Methodology/Principal Findings: Expression of UPR-related genes was investigated in colonic and ileal biopsies of 23
controls, 15 ulcerative colitis (UC) and 54 Crohn’s disease (CD) patients. This expression was confirmed at protein level in
colonic and ileal samples of five controls, UC and CD patients. HSPA5, PDIA4 and XBP1s were significantly increased in
colonic IBD at mRNA and/or protein levels, indicating activation of the ATF6 and IRE1 branch. Colonic IBD was associated
with increased phosphorylation of EIF2A suggesting the activation of the PERK branch, but subsequent induction of
GADD34 was not observed. In ileal CD, no differential expression of the UPR-related genes was observed, but our data
suggested a higher basal activation of the UPR in the ileal mucosa of controls. This was confirmed by the increased
expression of 16 UPR-related genes as 12 of them were significantly more expressed in ileal controls compared to colonic
controls. Tunicamycin stimulation of colonic and ileal samples of healthy individuals revealed that although the ileal mucosa
is exhibiting this higher basal UPR activation, it is still responsive to ER stress, even more than colonic mucosa.
Conclusions/Significance: Activation of the three UPR-related arms is seen in colonic IBD-associated inflammation.
However, despite EIF2A activation, inflamed colonic tissue did not increase GADD34 expression, which is usually involved in
re-establishment of ER homeostasis. This study also implies the presence of a constitutive UPR activation in healthy ileal
mucosa, with no further activation during inflammation. Therefore, engagement of the UPR differs between colon and
ileum and this could be a factor in the development of ileal or colonic disease.
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Introduction
Inflammatory bowel disease (IBD) is a group of chronic,
inflammatory disorders of the colon and/or small intestine. The
major types of IBD are Crohn’s disease (CD) and ulcerative colitis
(UC). Although the precise pathophysiology of the diseases
remains incompletely understood, recent studies link endoplasmic
reticulum (ER) stress to these inflammatory conditions.
ER stress is a phenomenon where the demand and capacity of
the ER for protein modification is imbalanced. Indeed, the
synthesis, folding and processing of secreted and membrane
proteins by the ER is a labor intensive task that requires the
functioning of ER chaperones, maintenance of ER calcium pools,
and an oxidative environment [1]. A variety of stimuli, including
virus infections, and endogenous imbalances in the cell, such as the
accumulation of unfolded or misfolded proteins, the loss of calcium
homeostasis, glucose deprivation, or the accumulation of free
cholesterol can increase stress to the ER [2,3]. To cope with
stressful conditions and to ensure correct protein folding,
eukaryotic cells have evolved the unfolded protein response
(UPR) which restores normal cell function by cessation of protein
translation, increase of chaperones production and degradation of
aberrant proteins [4,5]. In cases of sustained ER stress, apoptosis is
favored.
The UPR consists of three main signaling arms, each of which
starts from an ER transmembrane sensor protein: inositol
requiring enzyme 1 (IRE1), pancreatic ER kinase (PKR)-like ER
kinase (PERK) and activating transcription factor 6 (ATF6), which
sense the status of protein folding in the lumen of the ER [6,7,8].
In the absence of misfolded proteins, the three stress sensors exist
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5 (HSPA5) (commonly known as glucose regulated protein 78
(GRP78) or immunoglobulin heavy-chain binding protein (BiP))
[9]. Upon ER stress, HSPA5 binds to misfolded proteins and
therefore separates from ER sensors, resulting in the activation of
PERK, IRE1 and ATF6.
Following the release of HSPA5, PERK autophosphorylates
and then phosphorylates eukaryotic initiation factor 2 (EIF2A)
leading to the attenuation of cap-mediated translation [10,11,12].
However, selective translation of mRNAs involved in cell survival
and ER homeostasis are favored. One of the selectively translated
mRNAs is the transcription factor ATF4, which regulates genes
involved in ER functions, amino acid biosynthesis as well as
apoptosis [13,14,15]. A second known gene is the transcription
factor Nuclear factor-(erythroid-derived-2)-like-2 (Nrf2), whose
activation results in the expression of genes implicated in
antioxidant stress response [16]. Upon ER stress, ATF6 is
mobilized to the Golgi apparatus where it is cleaved by site-1
and site-2 proteases (S1P and S2P) resulting in the release of the
transcriptionally active ATF6p50 [13,17]. Active ATF6p50 directs
expression of genes encoding ER chaperones, ER associated
protein degradation (ERAD) components and molecules involved
in lipid biogenesis [18]. Activation of IRE1 results in the removal
of a 26 nucleotide fragment of the mRNA encoding the unspliced
transcription factor X-box-binding protein-1 (XBP1u) to generate
an active spliced version XBP1s [19,20,21]. XBP1s induces genes
involved in ER quality control, protein folding, maturation and
degradation, redox homeostasis and oxidative stress response [22].
XBP1u is a transcriptional target of active ATF6p50, exemplifying
the cross-talk between the ATF6 and IRE1 pathway [20,23].
In particular, the IRE1 pathway has been linked to intestinal
inflammation, through its effector transcription factor XBP1. The
XBP1 gene which resides at 22q12 has been linked to IBD
[24,25,26] and multiple single nucleotide polymorphisms in XBP1
were found to be associated with both CD and UC [27].
Epithelial-specific deletion of XBP1 in mice resulted in spontane-
ous ileitis and increased susceptibility to chemically induced colitis,
linking cell-specific ER stress to organ-specific inflammation [27].
In addition, the absence of IRE1 in mice led to an increased
susceptibility to experimental colitis [28].
In this study, we performed an extensive analysis of transcript
and protein levels of genes involved in the three UPR pathways in
colonic and ileal biopsies of healthy controls and patients with CD
and UC. Significant increase in transcript levels of HSPA5, PDIA4
and splicing of XBP1 was observed along with increased protein
concentrations of HSPA5, PDIA4 and pEIF2A/EIF2A in colonic
IBD-associated inflammation. Notably, GADD34, which is
involved in blocking the PERK pathway, was not observed to be
modulated. Whereas no significant induction of any of the three
pathways was seen in ileal inflammation, the majority of UPR-
related genes revealed a significantly increased expression in
healthy ileal tissue as compared to healthy colonic tissue. These
findings suggest a higher basal UPR engagement in ileal tissue,
most likely reflecting the presence of highly secretory cell types,
high concentrations of exogenous antigens and a higher metabolic
activity. Stimulation of colonic and ileal samples of healthy
controls with tunicamycin, a well-known inducer of ER stress,
revealed a higher response of the ileal mucosa compared to the
colonic mucosa, confirming that this higher basal level does not
prevent further UPR engagement. The increased response of the
ileum to alterations in the UPR is consistent with the spontaneous
development of ileitis in mouse models with deleted XBP1, where
the absence of XBP1 prevents its beneficial effect on ER
homeostasis and consequently increase the burden on the ER
[27]. Collectively, these results point to a role for the UPR in the
pathogenesis of IBD with different implications for colonic and
ileal disease.
Results
Correlation of endoscopic inflammation and
transcriptional expression of IL8
IL8 is used as a reliable marker of intestinal inflammation
[29,30,31]. An extensive set of colonic (Fig. 1A) and ileal samples
(Fig. 1B) of healthy controls, UC and CD patients was evaluated
for IL8 mRNA to confirm and define inflammation in endoscopic
pinch biopsies. For biopsy samples taken in endoscopically affected
areas, IL8 was increased by as much as 38-fold in UC (p,0.0001)
(Fig. 1A), 35-fold in colonic CD (p,0.0001) (Fig. 1A) and 35-fold
in ileal CD (p=0.001) (Fig. 1B) when compared to healthy
controls. Comparison of endoscopically non-inflamed samples of
active UC patients to healthy controls revealed no difference. In
contrast, IL8 was induced by as much as 17-fold (p,0.0001)
(Fig. 1A) in colonic samples and 8-fold (p=0.040) (Fig. 1B) in ileal
samples taken in endoscopically non-inflamed areas of active CD
patients, demonstrating a clear residual inflammation. This
observation also indicates that these non-inflamed areas are
dubious controls for inflamed areas. Mucosal specimens of both
UC and CD patients in remission had no increase in IL8
compared to controls, which correlates well with their clinical
classification (Fig. 1A–B). As expected, colonic samples of CD
patients with isolated ileal disease (CD-L1) (Fig. 1A), ileal samples
of CD patients with isolated colonic disease (CD-L2) (Fig. 1B) and
ileal samples of UC samples (Fig. 1B) showed no increase in IL8
expression.
ROC curve analysis was performed to analyze the sensitivity
and specificity of IL8 mRNA as a marker of inflammation in
endoscopically defined biopsies (Fig. 1C–F). A 90% specificity
resulted in a sensitivity of 61% for all colonic samples (Fig. 1C) and
a sensitivity of 65% for all ileal samples (Fig. 1D). Given the fact
that non-inflamed samples taken in CD patients with active disease
exhibited significant IL8 expression, their exclusion resulted in an
increased sensitivity of 94% for the colonic samples (Fig. 1E). No
improvement in sensitivity was seen for the ileal samples (Fig. 1F),
probably due to the high variability in IL8 levels among the ileal
samples. Given these results, we decided to analyze ER stress
signatures in biopsies retrieved from macroscopically inflamed
areas in IBD patients and compared them to the levels in healthy
controls only.
Transcriptional evaluation of genes involved in the three
UPR pathways implies an activation of the ATF6 and IRE1
pathway in inflamed samples of colonic IBD patients
The HSPA5 chaperone is a central mediator of ER stress and is
quickly induced by the UPR upon ER stress [32]. Quantitative
evaluation of HSPA5 mRNA in affected samples of IBD patients
revealed an increase of 2.6-fold in UC (p=0.0002) and 2.5-fold in
colonic CD (p=0.0003) when compared to healthy controls
(Fig. 2A). The same analysis in ileal samples revealed no significant
difference (Fig. 2A). As this is likely to represent UPR activation,
we were interested to dissect the activation of the three UPR
branches.
To investigate the ATF6 pathway, we measured PDIA4 as a
target gene. In colonic samples, UC biopsies show a 2.1-fold
induction (p=0.003) while CD biopsies exhibit a 1.8-fold
induction (p=0.003) when compared to colonic controls
(Fig. 2B). On the contrary, ileal CD biopsies did not show an
increased expression when compared to their controls (Fig. 2B).
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by the splicing of a 26-nucleotide intron from the inactive
unspliced XBP1 mRNA (XBP1u) which results in the generation of
spliced XBP1 mRNA (XBP1s) that encodes the active transcription
factor [32]. XBP1 splicing, expressed as the ratio of
XBP1s:(XBP1s+XBP1u) was increased 1.8-fold in UC (p=0.0001)
and 1.5-fold in colonic CD (p=0.002), while no differential
expression was observed in ileal disease (Fig. 2C).
Figure 1. Correlation of endoscopic inflammation and transcriptional expression of IL8. IL8 mRNA expression determined in A. colonic
and B. ileal mucosal samples is increased in biopsies taken in inflamed areas of inflammatory bowel disease (IBD) patients when compared to healthy
controls. In samples of patients in remission, colonic samples of Crohn’s disease (CD) patients with isolated ileal disease (CD-L1) and ileal sampleso f
CD patients with isolated colonic disease (CD-L2), IL8 levels are similar to healthy controls. Whereas no increase in IL8 is observed in samples taken in
endoscopically non-inflamed mucosa of active ulcerative colitis (UC) patients, a significant increase is seen in non-inflamed colonic samples of active
CD patients when compared to healthy controls. The data are expressed as medians and presented on a log scale (*p,0.05, **p,0.01, ***P,0.001,
#P,0.0001). A ROC curve analysis of IL8 was performed on all samples (C. colon and D. ileum) and when non-inflamed samples of active CD patients
were excluded (E. colon and F. ileum). The increase in sensitivity when excluding non-inflamed colonic samples of active CD patients confirms that
those samples are an inappropriate control for the study of inflammation.
doi:10.1371/journal.pone.0025589.g001
Figure 2. Transcriptional analysis of UPR-related genes. Transcript levels of A. HSPA5, B. PDIA4, C. XBP1s:(XBP1s+XBP1u), and D. GADD34
imply the activation of the ATF6 and IRE1 pathway in inflamed samples of ulcerative colitis (UC) and colonic Crohn’s disease (CD) patients, while no
differential expression was seen in ileal CD patients when compared to healthy controls. Levels in healthy controls (HC) were arbitrary set as 1, and UC
and CD levels expressed as the ratio to healthy controls (*P,0.05, **P,0.01, ***P,0.001).
doi:10.1371/journal.pone.0025589.g002
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negative feedback mechanism that dephosphorylates EIF2A and
restores protein translation [32]. In colonic IBD samples, we
observed similar expression levels of GADD34 as healthy controls,
while in ileal CD a decrease of 2.2-fold (p=0.017) was observed
(Fig. 2D). These data suggest either that PERK is not activated or
that it can’t induce its feedback mechanism.
Interestingly, we observed a high correlation between HSPA5
and IL8 mRNA levels in mucosal samples taken in healthy and
involved areas of UC (R
2=0.726, p,0.001) and colonic CD
(R
2=0.625, p,0.001), suggesting a link between inflammation
and ER stress. On the other hand, no correlation was found in
ileal tissue of healthy and inflamed biopsies (R
2=0.318, not
significant), suggesting an inflammation-independent expression of
UPR genes in this context.
Transcript levels of UPR-related genes are increased in
samples of ileal controls when compared to colonic
controls
As our transcriptional data showed an increased activation of
the UPR in colonic inflammation, while no increase was observed
in ileal inflammation, it raised the possibility that the two tissues do
not have the same basal activation of the UPR and therefore do
not engage it equally in an inflammatory situation. To explore the
possibility of a different basal UPR activity in the colon when
compared to the ileum, we evaluated transcript levels of an
extended set (n=16) of UPR-related genes in colonic and ileal
samples of healthy controls (Table 1). Interestingly, 12 out of the
16 analyzed genes had significant higher expression levels in ileal
samples when compared to colonic samples. This suggests that the
ileum experiences a higher level of UPR activation in healthy
controls.
Protein analysis confirms the mRNA data demonstrating
an increased UPR activation in colonic IBD
In order to confirm mRNA data, we were interested to
investigate UPR-related proteins using colonic and ileal samples of
five healthy controls, five active UC and five active CD patients.
Particularly, we assessed HSPA5, PDIA4, XBP1s, EIF2A, pEIF2A
and GADD34 by immunoblotting (Fig. 3A en Fig. 3B) and
quantified the signals (Fig. 3C–G).
Concerning colonic samples (Fig. 3A), a significantly increased
concentration of HSPA5 was observed in inflamed samples of UC
patients when compared to healthy controls (Fig. 3C). Further-
more, a significant increase in PDIA4 concentration was observed
in inflamed samples of both UC and CD patients, which could
reflect the activation of ATF6 (Fig. 3D). The activation of IRE1
was assessed by the presence of the prototypical XBP1s, but no
significant differential expression was observed in colonic inflamed
samples of IBD patients (Fig. 3E). Activation of the PERK branch
results in the phosphorylation of EIF2A, and significant increase in
levels of pEIF2A/EIF2A was demonstrated in inflamed colonic
IBD samples (Fig. 3G). No significant differential expression of
GADD34 protein was observed (Fig. 3F). Concerning ileal samples
(Fig. 3B), concentrations of HSPA5, PDIA4, XBP1s, GADD34
and pEIF2A in ileal control samples were comparable to those
observed in inflamed samples of ileal CD patients (Fig. 3B, C, D,
E, F and G). Interestingly, protein levels correlated generally with
our mRNA data and when not significant, a similar trend was
observed.
UPR activation with tunicamycin results in a more
pronounced induction of HSPA5 in ileal controls when
compared to colonic controls
The basal activation of the UPR in the healthy ileal tissue
questions the capacity of the ileum to establish any further ER
stress response, a fact that could artificially mask the increase due
to a pathologic situation. To test whether the ileal tissue is still
responsive to ER stress stimuli, we stimulated paired colonic and
ileal mucosal samples of five healthy controls with tunicamycin.
Tunicamycin blocks protein glycosylation (by inhibition of N-
acetylglucosamine transferases) and consequently induces the
UPR. Transcriptional analysis of HSPA5 revealed an increased
expression in both tunicamycin stimulated colonic and ileal
mucosal samples when compared to unstimulated samples
(Fig. 4). In addition, a more pronounced induction was observed
in ileal samples (mean: 3.8 fold; range 2.1 to 5.9 fold) when
compared to colonic samples (mean: 2.0 fold; range 1.2 to 3.0 fold)
(p=0.048). This shows that although the ileum lives with a higher
basal UPR engagement (Table 1), it remains responsive to further
ER stress induction.
ER stress is mainly localized in the epithelial lining of the
gut
An elevation of ER stress in the whole tissue could reflect either
an increase of ER stress in the local tissue, or a more marked ER
stress in inflammatory cells recruited to the site of inflammation.
To delineate which of these possibilities is involved in our results,
we performed immunohistochemistry using HSPA5, a central
chaperone induced upon ER stress. HSPA5 was mainly localized
to the epithelial lining of the gut and in Paneth cells, positive signal
also comes from inflammatory cells (Fig. 5A–E). A clear increase
was mainly observed within the epithelial compartment that stains
weakly in healthy controls and increases noticeably in inflamed
samples of IBD patients.
Table 1. Fold changes and significance values of normalized
transcript levels in mucosal samples of ileal controls (n=17)
when compared to colonic controls (n=20).
Gene symbol p value Fold
HSPA5 ,0.0001 +1,96
XBP1_U 0.002 +2,06
XBP1_S ,0.0001 +1,98
PDIA4 ns +1,38
HMOX1 0.0006 +1,72
GADD34 0.003 +2,36
DDIT3 0.033 +1,53
EIF2A ns +1,33
ATF6 0.0001 +1,82
ERO1L 0.005 +2,24
ERN1 0.033 +2,75
ATF4 0.007 +1,79
NQO1 ns +0,56
PERK ns +1,50
DNAJC3 0.003 +1,59
ERDJ4 0.004 +2,46
doi:10.1371/journal.pone.0025589.t001
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ER stress is a common feature of intestinal secretory cells such
as Paneth cells, enteroendocrine cells and to a lesser extent goblet
cells. A number of physiological processes and environmental
factors which include bacteria, metabolic factors, drugs, hypoxia
and inflammation promote the secretory activity of these cells, thus
inducing stress on the protein quality control machinery. Genome
wide linkage studies associate 22q12, the region where XBP1
resides, with genetic susceptibility to IBD [24,25,26]. Recently,
multiple single nucleotide polymorphism in XBP1 were found to
be associated with both UC and CD [27]. XBP1 is a critical
transcription factor of the IRE1 branch of the UPR and it is
activated when unfolded or misfolded proteins accumulate in the
ER. In addition, mouse models link the IRE1 pathway to intestinal
inflammation and reveal its importance in secretory cells [27,28].
Figure 3. Western Blot analysis of UPR-related proteins. Immunoblotting was performed on A. colonic and B. ileal samples of 5 healthy
controls (HC), 5 active ulcerative colitis (UC) and 5 active Crohn’s disease (CD) patients. Signals of HSPA5 (Fig. 3C), PDIA4 (Fig. 3D), XBP1s (Fig. 3E),
GADD34 (Fig. 3F), and pEIF2A/EIF2A (Fig. 3G), were quantified. In colonic samples, significant increased concentrations of PDIA4 and pEIF2A/EIF2A
were observed in both UC and CD patients, while a significant increase in HSPA5 was only found in UC patients. In ileal samples, no differential
expression of the UPR-related proteins was observed. Levels in healthy controls were arbitrary set as 1, and UC and CD levels expressed as the ratio to
healthy controls (*P,0.05, **P,0.01).
doi:10.1371/journal.pone.0025589.g003
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spontaneous ileitis and increased susceptibility to chemically
induced colitis [27]. The extensive ileal inflammation was
accompanied with the absence of Paneth cells and a significant
reduction in goblet cells. In our study, we performed an extensive
analysis of transcript and protein levels of human genes involved in
the three UPR pathways in colonic and ileal biopsies of healthy
controls and patients with UC and CD.
Inflammation is the first protective response of a tissue to
infection or injury in order to initiate the healing process. On the
opposite, chronic inflammation which is a hallmark of IBD is a
prolonged inflammation detrimental to the tissue. IL8 is a well-
documented marker of colonic inflammation, and both IL8
protein and mRNA levels correlate with the degree of inflamma-
tion [29,30,31]. In agreement with previous studies, we found an
increase of IL8 mRNA in biopsy samples taken in involved mucosa
of IBD patients. In other situations where no inflammation is
expected, no increase in IL8 was observed; mucosal samples of
IBD patients in remission, colonic samples of CD patients with
isolated ileal disease -CD-L1-, ileal samples of CD patients with
isolated colonic disease -CD-L2- as well as ileal samples of UC
samples. Additionally, our data reveals the complexity of using
endoscopically non-inflamed samples of active CD patients as
antithesis for inflamed samples. Indeed, whereas in UC patients a
continuous inflammation with a sharp delineation between the
involved and non-involved mucosa is seen, inflammation in CD
patients is characterized by the presence of endoscopically non-
involved mucosa between affected regions, known as ‘skip’ lesions.
No increase in IL8 expression was observed in samples taken in the
non-inflamed mucosa of active UC patients, while in the non-
inflamed mucosa of active CD patients a significant increase in IL8
was found. A ROC curve analysis including or excluding non-
inflamed samples of active CD patients confirmed that the
inclusion of those non-inflamed samples cause a decrease of
almost 30% in sensitivity for IL8. In conclusion our results show
that the use of endoscopically non-inflamed samples of active CD
patients does not represent an appropriate control for the study of
molecular inflammation.
We first investigated UPR activation by HSPA5 expression.
HSPA5, also known as GRP78 or BiP, is a central player in ER
homeostasis. Under homeostatic conditions, the luminal domain of
the proximal sensors ATF6, IRE1 and PERK1 interacts with
HSPA5, inactivating these signaling pathways. Upon accumula-
tion of unfolded or misfolded proteins, HSPA5 dissociates from
these molecules, allowing their activation [29,30,31]. The
transcriptional activation of the HSPA5 promoter is regarded as
a reliable measure of ER stress [33]. Literature reports increased
HSPA5 mRNA levels in colonic [34,27,35] and ileal [27] samples
of involved areas of IBD patients. In line with these data, our
results demonstrated significant increased HSPA5 transcript and/
or protein levels in involved areas of colonic IBD patients. In
contrast to the study of Kaser, we found no differential expression
of HSPA5 between ileal samples of healthy controls and active CD
patients [27]. However, we suspect that this could be due to the
use of a limited sample size in the study of Kaser, along with an
important variability in the expression of ileal HSPA5 protein (as
we observed in fig. 3B). Nonetheless, our data reflects well
activation of the UPR as not only HSPA5 was modulated, but also
other transcript and/or protein levels: PDIA4, XBP1s and
pEIF2A. These were found to be increased in colonic IBD, while
no differential expression of both transcript and protein levels were
observed in ileal CD. In this context, we are confident that our
results reflect fairly the situation given the reasonable number of
biological replicates, the analysis of multiple UPR-related genes
and the correlation between transcript and protein levels in our
work.
Our investigation of the various UPR-related molecules at the
protein levels correlated relatively well the results obtained by
qRT-PCR, which is a technique far more sensitive. But the
correlation is not perfect and this could be caused by a
combination of factors: restricted biopsy samples in immunoblot-
ting, lower sensitivity of this technique, and induction of ER stress
by the biopsy technique itself, as it is reported in other tissues [36].
Nonetheless, we consider that the global picture strengthens the
findings made by qRT-PCR.
An expanded qPCR analysis of 16 UPR-related genes
confirmed that a higher basal UPR activity is in place in the
ileal mucosa of healthy controls when compared to the colonic
mucosa. In this analysis, twelve genes (HSPA5, XBP1_U, XBP1_S,
PDIA4, HMOX1, GADD34, DDIT3, EIF2A, ATF6, ERO1L, ERN1,
ATF4, NQO1, PERK, DNAJC3, and ERDJ4) had significantly higher
transcript levels in samples of ileal controls than in colonic
controls, clearly showing that the two tissues live with a different
basal activation of the UPR.
A growing body of evidence suggests that ER stress and
inflammation are interconnected. HSPA5 is a reliable marker for
ER stress and IL8 is a marker for inflammation. We found a strong
correlation between these two in both UC and colonic CD, but a
lack of correlation was found in ileal CD. This is coherent with the
increased UPR activation observed in the colonic tissue of active
IBD patients, whereas no increase was seen in the ileal tissue of
active CD patients. In the ileum, ER stress is probably dictated by
other local factors. The ileum contains a high number of Paneth
cells, has an increased number of mucosa-associated E. coli and
has a higher metabolic activity compared to the colon. This might
contribute to a constitutive triggering of the UPR in the ileal
mucosa, which is critical in maintaining homeostasis. The fact that
inflammation does not further increase UPR in ileal samples either
reflects that the higher basal levels observed can buffer some
perturbations or reflect that the ileum is less sensitive to
perturbations through inflammation. This leads us to consider
that the colonic mucosa is subject to a lower ER stress, with a
Figure 4. Tunicamycin induces ER stress in mucosal samples of
healthy controls. Stimulation of paired colonic and ileal samples of
five healthy controls with the ER stress inducer tunicamycin revealed an
increased expression of HSPA5 mRNA in both colonic and ileal tissue,
with a more pronounced induction in the ileal mucosa (*P=0.048). Bars
represent the fold induction of HSPA5 in treated samples relative to
untreated samples.
doi:10.1371/journal.pone.0025589.g004
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levels of UPR, any induction is more uniform and more noticeable
in this tissue.
In order to determine whether the ileum could still respond to
ER stress, paired colonic and ileal samples of five healthy controls
were stimulated with tunicamycin, a well-known ER stress inducer
[37,38]. Both colonic and ileal samples revealed higher HSPA5
transcript levels in the tunicamycin stimulated samples. In
addition, a higher induction was observed in the ileal samples.
This would argue that the ileum rather lives on a higher basal ER
stress, but can still induce strongly the gene response. It also
highlights that if the inflammation of the tissue did not significantly
increase the UPR, it is not because the tissue is unable to do so.
Indeed if the UPR is more activated in basal state, removal of a
protective arm (XBP1) would prevent proper re-establishment of
homeostasis and could logically result in imbalance. This would be
coherent with both our findings and the ones of Kaser [27].
Moreover, in the study of Kaser, XBP1 was deleted exclusively in
epithelial cells, pointing toward a defect in epithelial cells in IBD
pathogenesis. In our study, we observed that HSPA5 located
mainly in intestinal epithelial secretory cells (enteroendocrine cells,
paneth cells and goblet cells) which produce large amounts of
proteins involved in mucosal defense.
Regarding the activation of the PERK branch, transcript and
protein levels of GADD34 in colonic IBD patients were similar to
healthy controls, which would argue against an activation of the
PERK pathway. In contrast, western blot analysis showed an
increased concentration of pEIF2A in colonic inflammation. If
pEIF2A would result from PERK activation, we would expect an
induction of GADD34, which is the co-factor of protein
phosphatase 1 in the dephosphorylation of pEIF2A [32]. This
would represent the canonical PERK pathway, where GADD34
promotes the return to homeostasis of the ER. As we do not
observe a significant difference in GADD34, we could hypothesize
that phosphorylation of EIF2A results from another pathway, such
as protein kinase RNA-activated (PKR). Another possibility is that
Toll-like-receptor signaling prevents induction of DNA damage
inducible transcript 3 (DDIT3) also known as C/EBP homologous
Figure 5. ER stress is mainly localized in epithelial secretory cells. Immunohistochemical analysis of HSPA5, a central mediator of ER stress,
was performed on paraffin embedded slides of A. colonic controls, B. inflamed areas of colonic Crohn’s disease (CD) patients, C. inflamed areas of
ulcerative colitis patients, D. ileal controls and E. inflamed areas of ileal CD patients. The ER stress observed is linked to the epithelium rather than to
recruited inflammatory cells.
doi:10.1371/journal.pone.0025589.g005
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does not suppress phosphorylation of PERK or EIF2A, which are
upstream of CHOP, but pEIF2A fails to promote translation of the
CHOP activator ATF4. As CHOP is responsible for GADD34
induction, this would also be inhibited even in a context where
PERK is active.
Given that multiple SNPs within XBP1 have been found to be
associated with CD and UC, we should keep in mind that these
SNPs could influence the regulation of genes involved in the UPR
[27]. It will be important to study the impact of XBP1 mutations
on the IBD phenotype, but also on the full ER stress signatures in
the gut. We believe however that the high baseline UPR activation
and the increased sensitivity of ileal tissue is not influenced by
SNPs, as colonic and ileal biopsies have been retrieved from the
same individuals.
In conclusion, this study provides human data consistent with
the observations in mice with conditional deletion of XBP1 in the
epithelium [27]. A distinct UPR activation between colonic and
ileal disease was shown by 1) increased activation of the UPR in
inflamed regions of patients with colonic IBD and not in patients
with ileal CD and 2) higher basal ER stress levels in healthy ileal
mucosa when compared to the colonic mucosa. Despite these
differences, the ileal tissue is not limited in its activation of the
UPR upon induction of ER stress, but on the contrary proved to
be more responsive to ex vivo ER stress stimulation. In addition our
results point to the presence of an inflammation-related ER stress
signature in colonic IBD.
Materials and Methods
Ethics statement
The study was in accordance with the guidelines of the Helsinki
Declaration (1964 and amended in 1975, 1983, 1989, 1996 and
2000) of the World Medical Association. This study was approved
by the ethics committee of Ghent University Hospital (permit
number EC UZG 2004/242) and each participant obtained a
written informed consent form. This form was signed by the
participants.
Patients and samples used for qRT-PCR
A total of 173 macrodissected intestinal tissue samples from 23
healthy controls, 15 UC patients and 54 CD patients were obtained
during colonoscopy with a Single-Use Biopsy Forceps Radial Jaw3
(Boston Scientific, El Coyol, Costa Rica) (Table 1). The size of a
biopsy specimen was between 2–4 mm
2 with an average weight of
6.4 mg. UC and CD patients were diagnosed based on clinical,
endoscopic and histological criteria. The Montreal Classification, a
subclassification of IBD patients is shown in table 2 [40]. In patients
with endoscopic signs of disease activity both inflamed and non-
inflamed samples were retrieved; the non-inflamed samples were
taken outsidethe inflamed part. Samples of patients in remission are
defined as samples of patients with an extinguished inflammation.
Colonic samples of CD patients with isolated ileal disease and ileal
samples of CD patients with isolated colonic disease were used as
uninvolved tissue. Samples from healthy controls were taken from
the ileum and sigmoid of patients who underwent colonoscopy to
screen for cancer or polyps. All biopsies collected during
colonoscopy were immediately stored in RNALater (Ambion,
Cambridgeshire, UK) at 280uC.
RNA extraction, cDNA synthesis and amplification
Total RNA was extracted from 2 pooled mucosal samples using
an RNeasy Mini Kit (Qiagen, Westburg BV, The Netherlands)
with on-column DNAse treatment (Qiagen). Needle homogeniza-
tion was performed. Purity and quantity of total RNA was assessed
using spectrophotometry (Nanodrop; Thermo Scientific, Wilming-
ton, USA). The ratio of absorptions at 260 nm and 280 nm were
used to define RNA purity; samples with a 260:280 ratio between
1.8 and 2.0 were accepted. Total RNA extraction yielded an
average of 5.5 mg. The RNA quality indicator (RQI) of 138
randomly chosen RNA samples was checked by automated
electrophoresis (Experion, Bio-Rad, Hercules, California) and
ranged from 7.5 to 10 with an average of 8.6. Starting from 20 ng
of total RNA, the WT-Ovation RNA Amplification System
(Nugen Technologies Inc., San Carlos, USA) was used according
to the manufacturer’s instructions, generating approximately 6 mg
of cDNA. In short, first strand cDNA was prepared from total
RNA using both oligo-dT and random hexamer primers and
reverse transcriptase. After the generation of double strand cDNA,
a DNA amplification step developed by NuGEN was performed.
cDNA was diluted to 50 ml.
Quantitative real-time PCR
PCR amplification reactions were carried out in a total volume
of 8 ml containing 26 SYBR Green I Master Mix (Eurogentec,
Seraing, Belgium), 3 ml 1/100 cDNA (,3.75 ng) and 250 nM
forward and reverse primers (BioLegio, Nijmegen, The Nether-
lands). All reactions were performed in duplicate in 384-well plates
(LightCycler 480 Multiwell Plates 384, white and LightCycler 480
Sealing Foils from Roche) on the CFX384 real-time PCR
detection system (Bio-Rad, Hercules, California), followed by a
regression Cq value determination method. Cycling conditions
were 95uC for 10 min followed by 45 cycles of 95uC for 10 s and
60uC for 30 s, followed by a dissociation curve analysis from 60 to
95uC. Primers containing neither SNPs nor secondary structures
were designed for GAPDH, SDHA, HPRT, IL8, HSPA5, XBP1u,
XBP1s, PDIA4, HMOX1, GADD34, DDIT3, EIF2A, ATF6, ERO1L,
ERN1, ATF4, NQO1, PERK, DNAJC3, and ERDJ4 (Table 3).
BLAST searches confirmed that only the target genes were
covered for 100%. A 6 point 4-fold standard dilution series
(highest concentration; 32 ng/ml) of a cDNA mixture of all
samples included in the study diluted in 5 ng/ml tRNA (Roche,
Basel, Switzerland) was used to test the PCR efficiency of the
primers. The dynamic range had to cover at least 3 orders of
dilution. Only primers with efficiency between 92% and 109%
were retained. Correlation coefficients of the targets were between
0.97 and 0.9996, with a mean of 0.991. The PCR efficiency for
each gene was calculated according to the equation E=10 (21/
slope). Each sample has been revised for a melting-curve with a
single sharp peak with a high correlation between the observed
and the expected Tm (mean variation of 0.53uC). Samples with
other patterns than a single sharp peak at the expected Tm,
defined as multiple peaks, a single broader peak or a shoulder
peak, were omitted. Cq values of samples with flattened melting-
curves were set as 45. An amplification signal in the no template
control (NTC) was ignored as long as the difference in Cq value
between the NTC and the highest Cq .5. Although the pre-
amplification method of NuGEN does not amplify genomic DNA,
possible contamination was assessed using intronic primers [41].
We confirmed that gDNA was undetectable in a dilution of up to
32 ng/ml cDNA. The mRNA expression level of each gene was
determined in Excel by using the comparative delta delta Cq
method and normalized to the geometric mean of the stably
expressed reference genes GAPDH, SDHA and HPRT as
determined by geNorm [42].
According to the MIQE guidelines, the minimum information
for publication of quantitative real-time PCR experiments was
provided [43].
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Colonic and ileal tissue samples from 5 healthy controls, 5 active
UC patients and 5 active CD patients were used for western
blotting. Each sample consisted of 2 biopsies and was lysed using
sonication for 1 min on ice in 150 ml RIPA lysis buffer containing
1:1000 DTT (Roche), 1:100 phosphatase inhibitor cocktail 2 and 3
(Sigma-Aldrich, St-Louis, Missouri), 1:50 protease inhibitor
EDTA-free (Roche) and 55 mg/ml beta-glycerophosphate (Alfa
Aesar, Karlsruhe, Germany). The insoluble material was removed
by centrifugation at 10 000 g for 5 min at 4uC. The concentra-
tions of protein lysates were determined by the BioRad protein
assay according to the manufacturer’s instructions using bovine
albumin as a protein standard.
Approximately 30 mg of each sample was mixed with 1:4
loading buffer (Invitrogen, San Diego, California) and 1:10
reducing agent (Invitrogen). Samples were denaturated by boiling
for 10 min at 96uC, separated on 4–12% Bis-Tris SDS-PAGE gels
(Invitrogen) and transferred to nitrocellulose membranes (GE
Healthcare, Waukesha, Wisconsin) according to the manufactur-
er’s instructions. After blocking non-specific binding sites with 5%
milk powder in Tris buffered saline with 0.1% Tween20 (TBST),
membranes were incubated with primary antibodies in TBST with
2.5% BSA at 4uC overnight. Rabbit anti-ERp72 (PDIA4), p-
EIF2A, EIF2A, BiP (HSPA5) were all from Cell Signaling
Technology (Cell Signaling Technology, Massachusetts, USA)
and diluted 1:1000. Rabbit anti-GADD34 (Santa Cruz, Califor-
nia, USA) and rabbit anti-XBP1 (Novus Biologicals, Colorado,
USA) were diluted 1:500. Next, blots were incubated with
1:10 000 horseradish peroxidase (HRP)-conjugated secondary
antibodies (Santa Cruz) in 2.5% milk for 1 hour at room
temperature. Bound antibodies were visualized using the
enhanced chemiluminescense (ECL) detection kit BM chemilumi-
Table 2. Characteristics of control subjects and inflammatory bowel disease patients.
Colonic biopsies
Healthy
controls
CD
remission
CD non-
inflamed
CD
inflamed CD-L1
UC
remission
UC non-
inflamed
UC
inflamed
N (Biopsies) 20 10 12 22 15 3 7 10
Gender (male/female) 7/13 4/6 3/9 10/12 9/6 3/0 4/3 5/5
Age, yrs (mean) 55 49 31 30 44 46 49 43
Age, yrs (range) 24–72 31–76 14–45 10–69 18–61 28–64 33–60 20–60
Age at diagnosis
A1, A2, A3 0/7/3 2/9/1 7/11/4 0/13/2 0/3/0 0/2/5 0/4/6
Location of disease
L1, L2, L3, L4 0/3/7/0 0/1/11/0 0/5/17/0 14/0/0/1
E1, E2, E3 0/1/2 1/5/1 1/5/4
Disease behavior
B1, B2, B3 5/4/1 (7
P) 6/4/2 (5
P) 16/4/2 (9
P) 7/2/6 (4
P)
Medication
No 7 8 17 9 3 3 4
5-aminosalicylates 3 4 5 6 0 4 6
Ileal biopsies
Healthy
controls
CD
remission
CD non-
inflamed
CD
inflamed CD-L2 UC
N (Biopsies) 17 12 4 20 9 10
Gender (male/female) 8/9 7/5 0/4 13/7 5/4 4/6
Age, yrs (mean) 54 44 27 36 47 37
Age, yrs (range) 29–72 15–69 10–53 11–58 26–69 20–52
Age at diagnosis
A1, A2, A3 2/8/2 2/2/0 3/16/1 0/4/5 0/7/3
Location of disease
L1, L2, L3, L4 3/0/9/0 1/0/3/0 12/0/8/0 0/8/0/1
E1, E2, E3 1/4/5
Disease behavior
B1, B2, B3 4/4/4 (8
P) 4/0/0 (0
P) 12/2/6 (6
P) 7/1/1 (4
P)
Medication
No 10 4 13 5 6
5-aminosalicylates 2 0 7 4 4
Age at diagnosis; A1: 0–16 yrs, A2: 16–40 yrs, A3: .40 yrs. Maximal location of disease; Crohn’s disease (CD); L1: solely ileal disease, L2: solely colonic disease, L3: ileal and
colonic disease, ulcerative colitis (UC); E1: ulcerative proctitis, E2: left-sided UC, E3: pancolitis. Maximal disease behavior; B1: non-stricturing, non-penetrating,
B2: stricturing, B3: penetrating, (X
P): number of patients when concomitant perianal disease was present.
doi:10.1371/journal.pone.0025589.t002
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turer’s instructions. Next, membranes were exposed to X-ray films.
Equal loading of proteins was confirmed by immunoblotting with
antibodies to actin (1:400) (Abcam, Cambridge, UK).
The Image J program (http://rsb.info.nih.gov/ij/) was used to
quantify western blot signals in each sample. The intensity of each
band was determined (P1) and background level (P0) was
subtracted (P2=P1-PO). For each protein and sample, this P2
value was then normalized to the P2 value of actin. Normalized
data were then used to generate the fold increase over the average
of healthy control.
Immunohistochemistry
Paraffin-embedded colonic and ileal sections of 3 controls, 3
active UC and 3 active CD patients were cut at a 5 mm thickness.
Deparaffinization, hydration, antigen unmasking and staining
were performed per manufacturer’s recommendations. In brief,
slides were boiled in 10 mM sodium citrate buffer to unmask the
Table 3. Sequences of qRT-PCR primers, amplicon lengths (bp), PCR efficiencies (%) and correlation coefficients(R
2).
Gene symbol Accession number Primer sequence (Forward and Reverse) Amplicon (bp) Efficiency (%) R
2
GAPDH NM_002046 F_TGCACCACCAACTGCTTAGC 87 91 0.9936
R_GGCATGGACTGTGGTCATGAG
SDHA NM_004168 F_TGGGAACAAGAGGGCATCTG 86 98 0.9947
R_CCACCACTGCATCAAATTCATG
HPRT NM_000194 F_TGACACTGGCAAAACAATGCA 94 92 0.9985
R_GGTCCTTTTCACCAGCAAGCT
IL8 NM_000584 F_GAATGGGTTTGCTAGAATGTGATA 129 99 0.9995
R_CAGACTAGGGTTGCCAGATTTAAC
HSPA5, BiP, GRP78 NM_005347 F_GGGAACGTCTGATTGGCGAT 69 106 0.9996
R_CGTCAAAGACCGTGTTCTCG
XBP1_U NM_005080 F_AGACAGCGCTTGGGGATGGAT 133 98 0.997
R_CCTGCTGCAGAGGTGCACGTAG
XBP1_S NM_001079539 F_AGACAGCGCTTGGGGATGGAT 107 103 0.9971
R_CCTGCACCTGCTGCGGACTC
PDIA4, ERp72 NM_004911 F_TCCCATTCCTGTTGCCAAGAT 121 99 0.9923
R_GCCCTCGTAGTCTACAGCCT
HMOX1 NM_002133 F_CAGTGCCACCAAGTTCAAGC 112 102 0.9867
R_GTTGAGCAGGAACGCAGTCTT
PPP1R15A, GADD34 NM_014330 F_TCCTCTGGCAATCCCCCATA 112 109 0.9984
R_GGAACTGCTGGTTTTCAGCC
DDIT3, CHOP NM_001195053 F_AAGGCACTGAGCGTATCATGT 105 102 0.9913
R_TGAAGATACACTTCCTTCTTGAACA
EIF2A NM_032025 F_CTGCACTCCTTCGATCTTCTG 68 105 0.9906
R_AGTTGTAGGTTGGGTATCCCAG
ATF6 NM_007348 F_TCAGACAGTACCAACGCTTATGC 113 97 0.9952
R_GTTGTACCACAGTAGGCTGAGA
ERO1L NM_014584 F_GCCAGGTTAGTGGTTACTTGG 141 108 0.9938
R_GGCCTCTTCAGGTTTACCTTGT
ERN1,IRE1 NM_001433 F_TTTGGAAGTACCAGCACAGTG 184 100 0.9911
R_TGCCATCATTAGGATCTGGGA
ATF4 NM_001675 F_GACCACGTTGGATGACACTTG 154 97 0.9976
R_GGGAAGAGGTTGTAAGAAGGTG
NQO1 NM_000903 F_GGCAGAAGAGCACTGATCGTA 145 96 0.9881
R_TGATGGGATTGAAGTTCATGGC
EIF2AK3, PERK NM_004836 F_TGCCTGGCTCGAAGCACCAC 112 101 0.97
R_TGGTGCATCCATTGGGCTAGGA
DNAJC3, P58IPK NM_006260 F_TTTGCGTTCACAAGCACTTAAC 101 94 0.97
R_GTTCTGCATCCCAAACACAAAC
DNAJB9, ERDJ4 NM_012328 F_GGTGTGCCAAAATCGGCATC 185 100 0.98
R_GCACTGTGTCCAAGTGTATCATA
doi:10.1371/journal.pone.0025589.t003
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hydrogen peroxidase, sections were blocked for 1 hour with 5%
normal goat serum in TBST. Incubation with the primary HSPA5
antibody (Cell signaling) was carried out at 1:200 for 24 hours at
4uC. Next, detection was achieved using the commercially
available Envision+ System-HRP kit (Dako), an HRP labeled
polymer which is conjugated with secondary anti-rabbit. HSPA5
was visualized with 39-3-diamino benzidene (Dako, California,
USA). Sections were counterstained with hematoxylin.
ER stress induction
Mucosal samples obtained during colonoscopy were immedi-
ately placed in RPMI supplemented with 10% fetal bovine serum
(Invitrogen), 2 mM glutaMAX-I supplement (Invitrogen), antibi-
otic-antimycotic cocktail (1006) (Invitrogen) and 200 mg/ml
geomycin for 15 min at 37uC. After a second wash for 15 min
at 37uC, paired colonic and ileal samples of five healthy controls
were stimulated for 24 hours with 2 mg/ml tunicamycin (Sigma-
Aldrich) or left unstimulated in RPMI supplemented with 10%
fetal bovine serum, 2 mM glutaMAX-I supplement, antibiotic-
antimycotic cocktail (1006) and 50 mg/ml geomycin. Each
condition was performed in duplicate. RNA was extracted as
previously described and converted to cDNA using iScript
according to the manufacturer’s guidelines. The mRNA expres-
sion level of HSPA5 was determined in Excel by using the
comparative delta delta Cq method and normalized to the
geometric mean of the stably expressed reference genes GAPDH,
SDHA and HPRT. The time point and concentration of
tunicamycin chosen in this study was determined in a pilot
experiment where a range of concentrations of tunicamycin
(500 ng/ml, 1 mg/ml, and 2 mg/ml) and time points (2 h, 4 h, 6 h,
8 h and 24 h) were tested. A concentration of 2 mg/ml
tunicamycin for 24 hours resulted in the highest induction for
HSPA5 mRNA.
Statistical analysis
Statistical analysis was performed using SPSS software 11.5
(SPSS, Chicago, USA). Statistical differences were assessed using a
non-parametrical Mann-Whitney U test (two tailed probabilities).
Correlations were calculated using Pearson’s Rho after log
transformation of the values to get a normal distribution of the
data. P-values less than 0.05 were considered significant.
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